Altman Dermatology Associates   Report issue

Academic/Hospital Phase 3
Founded: Arlington Heights IL United States

Organization Overview

First Clinical Trial
2010
NCT01188928
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4